BRANDY HOPSON: Open Payments
NPI 1891161345 · MAYNARDVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 71 payments from 13 companies in 2025. Trend: 2023 $1,155 · 2024 $1,211 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $379 |
| Novo Nordisk Inc | 19 | $302 |
| PFIZER INC. | 8 | $136 |
| Abbott Laboratories | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
Products named: VRAYLAR, Ozempic, ELIQUIS, UBRELVY, FREESTYLE LIBRE 3, AIRSUPRA, XIFAXAN, Wegovy.
Industry payments across TN — which companies pay providers there.
